FI940027A0 - Parannuksia itse varjoaineisiin tai parannuksia, jotka liittyvät niihin - Google Patents

Parannuksia itse varjoaineisiin tai parannuksia, jotka liittyvät niihin

Info

Publication number
FI940027A0
FI940027A0 FI940027A FI940027A FI940027A0 FI 940027 A0 FI940027 A0 FI 940027A0 FI 940027 A FI940027 A FI 940027A FI 940027 A FI940027 A FI 940027A FI 940027 A0 FI940027 A0 FI 940027A0
Authority
FI
Finland
Prior art keywords
pct
contrast agents
enhancements
sec
date
Prior art date
Application number
FI940027A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI940027A (fi
Inventor
Arne Berg
Jo Klaveness
Per Strande
Lars Stubberud
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26299192&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI940027(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB919114565A external-priority patent/GB9114565D0/en
Priority claimed from GB929200386A external-priority patent/GB9200386D0/en
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of FI940027A publication Critical patent/FI940027A/fi
Publication of FI940027A0 publication Critical patent/FI940027A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/226—Solutes, emulsions, suspensions, dispersions, semi-solid forms, e.g. hydrogels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Acoustics & Sound (AREA)
  • Animal Behavior & Ethology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI940027A 1991-07-05 1994-01-04 Parannuksia itse varjoaineisiin tai parannuksia, jotka liittyvät niihin FI940027A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919114565A GB9114565D0 (en) 1991-07-05 1991-07-05 Improvements in or relating to contrast agents
GB929200386A GB9200386D0 (en) 1992-01-09 1992-01-09 Improvements in or relating to contrast agents
PCT/EP1992/001477 WO1993000930A1 (en) 1991-07-05 1992-07-03 Improvements in or relating to contrast agents

Publications (2)

Publication Number Publication Date
FI940027A FI940027A (fi) 1994-01-04
FI940027A0 true FI940027A0 (fi) 1994-01-04

Family

ID=26299192

Family Applications (1)

Application Number Title Priority Date Filing Date
FI940027A FI940027A0 (fi) 1991-07-05 1994-01-04 Parannuksia itse varjoaineisiin tai parannuksia, jotka liittyvät niihin

Country Status (15)

Country Link
US (2) US5607661A (no)
EP (1) EP0593624B1 (no)
JP (1) JPH06510758A (no)
AT (1) ATE151993T1 (no)
AU (1) AU675050B2 (no)
CA (1) CA2112109A1 (no)
DE (1) DE69219337T2 (no)
DK (1) DK0593624T3 (no)
ES (1) ES2103376T3 (no)
FI (1) FI940027A0 (no)
GR (1) GR3023394T3 (no)
HK (1) HK1006945A1 (no)
IE (1) IE80926B1 (no)
NO (1) NO940015D0 (no)
WO (1) WO1993000930A1 (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9106686D0 (en) * 1991-03-28 1991-05-15 Hafslund Nycomed As Improvements in or relating to contrast agents
AU679428C (en) * 1991-09-17 2006-07-13 Ge Healthcare As Gaseous ultrasound contrast media and method for selecting gases for use as ultrasound contrast media
US5409688A (en) * 1991-09-17 1995-04-25 Sonus Pharmaceuticals, Inc. Gaseous ultrasound contrast media
MX9205298A (es) * 1991-09-17 1993-05-01 Steven Carl Quay Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
GB9200388D0 (en) * 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents
IL108416A (en) 1993-01-25 1998-10-30 Sonus Pharma Inc Colloids with phase difference as contrast ultrasound agents
US5558855A (en) * 1993-01-25 1996-09-24 Sonus Pharmaceuticals Phase shift colloids as ultrasound contrast agents
CA2154590C (en) * 1993-01-25 2001-06-12 Steven C. Quay Phase shift colloids as ultrasound contrast agents
JP3559849B2 (ja) * 1993-07-30 2004-09-02 アイエムシーオーアール ファーマシューティカル カンパニー 超音波技術のための安定化された微小気泡組成物
US5798091A (en) 1993-07-30 1998-08-25 Alliance Pharmaceutical Corp. Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
US5540909A (en) * 1994-09-28 1996-07-30 Alliance Pharmaceutical Corp. Harmonic ultrasound imaging with microbubbles
US5804162A (en) 1995-06-07 1998-09-08 Alliance Pharmaceutical Corp. Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
US5897851A (en) * 1995-06-07 1999-04-27 Sonus Pharmaceuticals, Inc. Nucleation and activation of a liquid-in-liquid emulsion for use in ultrasound imaging
DE19602930A1 (de) * 1996-01-18 1997-07-24 Schering Ag Poröse Matrices aus niedermolekularen Substanzen zur Genierung stabiler Gasblasensuspensionen, deren Verwendung als Ultraschallkontrastmittel sowie Verfahren zu deren Herstellung
IL126073A (en) * 1996-03-05 2002-02-10 Acusphere Inc Microencapsulated fluorinated gases for use as imaging agents
GB9622711D0 (en) * 1996-10-31 1997-01-08 British Tech Group Instrument having enhanced ultrasound visibility
US6054118A (en) * 1997-01-22 2000-04-25 Nycomed Imaging As Contrast agents comprising two types of gas-containing microparticles
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
WO1999042138A1 (en) * 1998-02-19 1999-08-26 University Of Virginia Patent Foundation The use of bjerknes forces to manipulate contrast agents
JP5078212B2 (ja) 2000-06-02 2012-11-21 ブラッコ・スイス・ソシエテ・アノニム 内皮細胞を標的とするための化合物、それを含む組成物およびその使用方法
JP3819845B2 (ja) * 2001-04-06 2006-09-13 ブラッコ・リサーチ・ソシエテ・アノニム 流体で充填された空洞内の局所物理パラメータの改善された測定方法
ES2506142T3 (es) 2002-03-01 2014-10-13 Dyax Corp. Péptidos de unión a KDR y a VEGF/KDR y su uso en diagnóstico
US7211240B2 (en) 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
EP1587944A4 (en) * 2002-03-01 2007-03-21 Dyax Corp KDR AND VEGF / KDR BINDING PEPTIDES AND THEIR USE FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
ES2396368T3 (es) 2003-03-03 2013-02-21 Dyax Corporation Péptidos que se unen específicamente al receptor del HGF (CMET) y usos de los mismos
SE526838C2 (sv) * 2003-11-27 2005-11-08 Xcounter Ab Undersökningsmetod och anordning för detektion av joniserande strålning
US20050255175A1 (en) * 2004-05-17 2005-11-17 Burgess W P Method for protecting nephron against injury caused by disruption of a chemical environment in the kidneys
US7019035B2 (en) * 2004-05-17 2006-03-28 Md Scientific Llc Method for attenuating free radical formation resulting from bodily insult
US20050255176A1 (en) * 2004-05-17 2005-11-17 Burgess W P Method for attenuating free radical formation resulting from bodily insult
US7625586B2 (en) 2004-10-28 2009-12-01 Md Scientific, Llc Method for mitigating injury to a kidney resulting from an ischemic event
US7999134B2 (en) * 2009-07-21 2011-08-16 Ge Healthcare As Crystallization of iodixanol using milling
US9827265B1 (en) 2012-04-06 2017-11-28 Md Scientific, Llc Method for attenuating free radical formation resulting from a bodily insult
US11504322B2 (en) 2014-08-28 2022-11-22 The General Hospital Corporation Injectable slurries and methods of manufacturing the same
US11471401B2 (en) 2014-08-28 2022-10-18 The General Hospital Corporation Injectable slurries and methods of manufacturing the same
JP6858698B2 (ja) * 2014-08-28 2021-04-21 ザ ジェネラル ホスピタル コーポレイション 注射可能なスラリーならびにその製造方法および使用方法
EP3419572A4 (en) 2016-02-26 2019-09-25 The General Hospital Corporation PRODUCTION OF A MEDICAL ICE GROUT, ADMINISTRATION SYSTEMS AND ASSOCIATED METHODS
JP7211699B2 (ja) * 2017-09-11 2023-01-24 バイエル ファーマ アクチエンゲゼルシャフト 超音波診断用造影剤
US11241330B1 (en) 2021-04-02 2022-02-08 Brixton Biosciences, Inc. Apparatus for creation of injectable slurry

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2680133A (en) * 1951-08-24 1954-06-01 Mallinckrodt Chemical Works Iodine-containing amino-benzoyl derivatives of amino acids
DE2629228C2 (de) * 1976-06-25 1984-10-18 Schering AG, 1000 Berlin und 4709 Bergkamen Jodierte Isophthalamsäure-Derivate Verfahren zu deren Herstellung sowie deren Verwendung
US4192859A (en) * 1978-09-29 1980-03-11 E. R. Squibb & Sons, Inc. Contrast media containing liposomes as carriers
ATE17311T1 (de) * 1980-11-17 1986-01-15 Schering Ag Praeparat zur erzeugung von mikroblaeschen.
US4572203A (en) * 1983-01-27 1986-02-25 Feinstein Steven B Contact agents for ultrasonic imaging
DE3313946A1 (de) * 1983-04-15 1984-10-18 Schering AG, 1000 Berlin und 4709 Bergkamen Mikropartikel und gasblaeschen enthaltende ultraschall-kontrastmittel
DE3834705A1 (de) * 1988-10-07 1990-04-12 Schering Ag Ultraschallkontrastmittel aus gasblaeschen und fettsaeure enthaltenden mikropartikeln
US4744989A (en) * 1984-02-08 1988-05-17 E. R. Squibb & Sons, Inc. Method of preparing liposomes and products produced thereby
US5354549A (en) * 1987-07-24 1994-10-11 Nycomed Imaging As Iodinated esters
DE3828905A1 (de) * 1988-08-23 1990-03-15 Schering Ag Mittel bestehend aus cavitate oder clathrate bildenden wirt/gast-komplexen als kontrastmittel
GB8900376D0 (en) * 1989-01-09 1989-03-08 Nycomed As Iodinated esters
US5215680A (en) * 1990-07-10 1993-06-01 Cavitation-Control Technology, Inc. Method for the production of medical-grade lipid-coated microbubbles, paramagnetic labeling of such microbubbles and therapeutic uses of microbubbles
US5205290A (en) * 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US5233995A (en) * 1991-11-21 1993-08-10 Sterling Winthrop Inc. Encapsulated particles useful as contrast agents in ultrasound and x-ray imaging compositions and methods

Also Published As

Publication number Publication date
DK0593624T3 (da) 1997-05-20
DE69219337D1 (de) 1997-05-28
IE922179A1 (en) 1993-01-13
CA2112109A1 (en) 1993-01-21
ATE151993T1 (de) 1997-05-15
IE80926B1 (en) 1999-06-30
US5607661A (en) 1997-03-04
WO1993000930A1 (en) 1993-01-21
FI940027A (fi) 1994-01-04
DE69219337T2 (de) 1997-10-09
EP0593624A1 (en) 1994-04-27
ES2103376T3 (es) 1997-09-16
AU675050B2 (en) 1997-01-23
US5772984A (en) 1998-06-30
NO940015L (no) 1994-01-04
AU2277292A (en) 1993-02-11
HK1006945A1 (en) 1999-03-26
JPH06510758A (ja) 1994-12-01
GR3023394T3 (en) 1997-08-29
EP0593624B1 (en) 1997-04-23
NO940015D0 (no) 1994-01-04

Similar Documents

Publication Publication Date Title
FI940027A0 (fi) Parannuksia itse varjoaineisiin tai parannuksia, jotka liittyvät niihin
DE58901585D1 (de) Mittel bestehend aus cavitate oder clathrate bildenden wirt/gast-komplexen als kontrastmittel.
ATE192339T1 (de) Verwendung von fulleren-derivaten in diagnostischen und/oder therapeutischen mitteln
NO306198B1 (no) Kovalent modifiserte mikropartikulaere kontrastmidler
ES2102813T3 (es) Composiciones farmaceuticas y dermocosmeticas que contienen calostro equino.
NO952533D0 (no) Vandige, injiserbare blandinger nyttige for röntgendiagnose, omfattende joderte aromatiske forbindelser anvendt som röntgenstrålekontrastmedium
ES2086771T3 (es) Composicion dermatologica y/o cosmetologica que contiene retinoides.
ES2101860T3 (es) Percarbonato de sodio encapsulado, estable al almacenamiento, y procedimiento para su preparacion.
DE69320173D1 (de) Kontrastmittel
DK0633763T3 (da) Kosmetiske eller farmaceutiske sammensætninger indeholdende deacylerede glycerophospholipider til topisk brug
ATE204021T1 (de) Klonierung, expression und charakterisierung einer neuen form der phosphatidylinositol-3- kinase
MX9203100A (es) Nuevos peptidos, su preparacion y su aplicacion.
RS49734B (sr) Primena intravenoznih kontrastnih sredstava za projekcionu mamografiju
DK0649433T3 (da) Antigeniske regioner fra komplekser af tumorfrigivne partikler (TLP) og antistoffer mod sådanne.
DK0482108T3 (da) Substituerede 2-imidazoliner samt fremstilling og anvendelse deraf
NO951657D0 (no) Nöytral selvglansemulsjon for pleie av gulv (III)
ES2144648T3 (es) Prevencion de la hemolisis mediante agentes tensioactivos.
DE69323191D1 (de) Wasserlösliche retinoide
DK0614457T3 (no)